This week, five Medical Devices stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Winner Medical Group (NASDAQ:WWIN) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
The rating of Cynosure Inc. (NASDAQ:CYNO) moves up this week, rising from a B to an A. Cynosure develops, manufactures, and markets aesthetic treatment systems to the dermatology, plastic surgery, and general medical markets. Shares of CYNO have increased 5.9% over the past month, better than the 2.5% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of CYNO stock.
RTI Biologics (NASDAQ:RTIX) is making progress this week as its rating of C (“hold”) from last week increases to a B (“buy”) rating this week. RTI Biologics processes human and animal musculoskeletal tissues in producing allograft and xenograft implants. Wall Street has pushed the stock higher by 7.2% over the past month. For more information, get Portfolio Grader’s complete analysis of RTIX stock.
This is a strong week for Edwards Lifesciences (NYSE:EW). The company’s rating climbs to B from the previous week’s C. Edwards Lifesciences provides products and technologies related to the treatment of advanced cardiovascular diseases. For more information, get Portfolio Grader’s complete analysis of EW stock.
Thoratec’s (NASDAQ:THOR) ratings are looking better this week, moving up to a B from last week’s C. Thoratec is involved in the development, manufacture and marketing of proprietary medical devices used for circulatory support. For more information, get Portfolio Grader’s complete analysis of THOR stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.